Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2018 | 1 |
2020 | 1 |
2024 | 0 |
Search Results
2 results
Results by year
Filters applied: . Clear all
Page 1
Crizotinib in advanced non-small-cell lung cancer with concomitant ALK rearrangement and c-Met overexpression.
BMC Cancer. 2018 Nov 26;18(1):1171. doi: 10.1186/s12885-018-5078-y.
BMC Cancer. 2018.
PMID: 30477470
Free PMC article.
METHODS: Totally, 4622 advanced NSCLC patients from two institutes (3762 patients at the Guangdong Lung Cancer Institute from January 2011 to December 2016 and 860 cases at the Perking Cancer Hospital from January 2015 to December 2016) were screened for ALK rearrangement …
METHODS: Totally, 4622 advanced NSCLC patients from two institutes (3762 patients at the Guangdong Lung Cancer Institute from January …
Wait-and-See Treatment Strategy Could be Considered for Lung Adenocarcinoma with Special Pleural Dissemination Lesions, and Low Genomic Instability Correlates with Better Survival.
Chen Y, Tang WF, Lin H, Bao H, Li W, Wang A, Wu X, Su J, Lin JS, Shao YW, Yang XN, Wu YL, Zhong WZ.
Chen Y, et al.
Ann Surg Oncol. 2020 Oct;27(10):3808-3818. doi: 10.1245/s10434-020-08400-1. Epub 2020 Apr 1.
Ann Surg Oncol. 2020.
PMID: 32239339
Item in Clipboard
Cite
Cite